Determination of potential health effects in the mouse comparing intranasal and peroral exposure to Pseudomonas aeruginosa and Escherichia coli

Microbial Ecology in Health and Disease

Volumn 9, Issue 4, 1996, Pages 143-156

  George, S E ^a   Kohan, M J ^a   Nelson, G M ^a   Schlundt, J ^b  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b National Food Agency of Denmark   (Denmark)

Author keywords

biotechnology agents; Escherichia coli; intranasal exposure; peroral exposure; Pseudomonas aeruginosa

Indexed keywords

ESCHERICHIA COLI; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0029907803     PISSN: 0891060X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1234-987X(199607)9:4<143::AID-MEH423>3.3.CO;2-1     Document Type: Article

References (46)

1. Abimiku AG, Dolby JM. (1987). The mechanism of protection of infant mice from intestinal colonisation with Campylobacter jejuni. Journal of Medical Microbiology 23, 339-344.
2. Anderson ES. (1975). Viability of, and transfer of a plasmid from, E. coli K12 in the human intestine. Nature 255, 502-504.
3. Baker NR, Minor V, Deal C, Shahrabadi MS, Simpson DA, Woods DE. (1991). Pseudomonas aeruginosa exoenzyme S is an adhesin. Infection and Immunity 59, 2859-2863.
4. Berg RD. (1992). Translocation of enteric bacteria in health and disease. Current Studies of Hematology and Blood Transfusion 59, 44-65.
5. Berg RD, Garlington AW. (1979). Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infection and Immunity 23, 403-411.
6. Bessa SM, Dalmasso AP, Goodale FL Jr. (1974). Studies on the mechanism of endotoxin-induced increase of alveolocapillary permeability. Proceedings of the Society for Experimental Biological Medicine 147, 701-705.
7. Body GP, Bolivar R, Fainstein V, Jadeja L. (1983). Infections caused by Pseudomonas aeruginosa. Reviews of Infectious Disease 5, 279-313.
8. Body GP, Rodriguez V, Chang JY, Narboni G. (1978). Fever and infection in leukemic patients. Cancer 41, 1610-1622.
9. Chatterjee DK, Chakrabary AM. (1982). Genetic rearrangements in plasmids specifying total degradation of chlorinated benzoic acids. Molecular and General Genetics 188, 279-285.
10. Clark JD. (1971). Influence of antibiotics or certain intestinal bacteria on orally administered Candida albicans in germ-free and conventional mice. Infection and Immunity 4, 731-737.
11. Cohen PS, Pilsucki RW, Myhal ML, Rosen CA, Laux DC, Cabelli VJ. (1979). Colonization potentials of male and female E. coli K12 strains, E. coli B and human fecal E. coli strains in the mouse GI tract. Recombinant DNA Technology Bulletin 2, 106-113.
12. De Freitas JR, Germida JJ. (1991). Pseudomonas cepacia and Pseudomonas putida as winter wheat inoculants for biocontrol of Rhizoctonia solani. Canadian Journal of Microbiology 37, 780-784.
13. Duval-Iflah Y, Chappuis JP. (1984). Influence of plasmids on the colonization of the intestine by strains of Escherichia coli in gnotobiotic and conventional animals. In: Klug MJ, Reddy CA (eds), Current Perspectives in Microbial Ecology. American Society for Microbiology, Washington, DC, pp. 264-272.
14. Federal Register. (1986). Coordinated framework for regulation of biotechnology; announcement of policy and notice for public comment. Federal Register 51, 23 302-23 393.
15. George SE, Kohan MJ, Gilmour MI, Taylor MS, Brooks HG, Creason JP, Claxton LD. (1993). Pulmonary clearance and inflammatory response in C3H/HeJ mice after intranasal exposure to Pseudomonas spp. Applied and Environmental Microbiology 59, 3585-3591.
16. George SE, Kohan MJ, Taylor MS, Brooks HG, Creason JP, Claxton LD. (1994). Intestinal survival, competition and translocation of biotechnology agents on intranasal exposure of C3H/HeJ mice. Environmental Toxicology and Chemistry 13, 1145-1152.
17. George SE, Kohan MJ, Whitehouse DA, Creason JP, Claxton LD. (1990). Influence of antibiotics on intestinal tract survival and translocation of environmental Pseudomonas species. Applied and Environmental Microbiology 56, 1559-1564.
18. George SE, Kohan MJ, Whitehouse DA. Creason JP, Kawanishi CY, Sherwood RL, Claxton LD. (1991). Distribution, clearance, and mortality of environmental pseudomonads in mice upon intranasal exposure. Applied and Environmental Microbiology 57, 2420-2425.
19. Goodnow RA, Katz G, Haines DC, Terrill JB. (1990). Subacute inhalation toxicity study of an ice-nucleation-active Pseudomonas syringae administered as a respirable aerosol to rats. Toxicology Letters 54, 157-167.
20. Guiot HFL, van der Meer JWM, van Furth R. (1981). Selective antimicrobial modulation of human microbial flora: infection prevention in patients with decreased host defense mechanisms by selective elimination of potentially pathogenic bacteria. Journal of Infectious Disease 143, 644-654.
21. Hardoyo, Yamada K, Shinjo H, Kato J, Ohtake H. (1994). Production and release of polyphosphate by a genetically engineered strain of Escherichia coli. Applied and Environmental Microbiology 60, 3485-3490.
22. Hentges DJ, Stein AJ, Casey SW, Que JU. (1985). Protective role of intestinal flora against infection with Pseudomonas aeruginosa in mice: influence of antibiotics on colonization resistance. Infection and Immunity 47, 118-122.
23. Kawanishi CY, George SE, Sherwood RL. (1990). Health effects assessment of pulmonary exposure to biotechnology agents. Review of Progress in the Biotechnology-Microbial Pest Control Agent Risk Assessment Program EPA/600/9-90/029, 214-215.
24. Kilbane JJ, Chatterjee DK, Karns JS, Kellogg ST, Chakrabarty AM. (1982). Biodegradation of 2,4,5-trichlorophenoxyacetic acid by a pure culture of Pseudomonas cepacia. Applied and Environmental Microbiology 44, 72-78.
25. Laux DC, Myhal ML, Cohen PS. (1981). Relative colonization potentials of E. coli K-12 and human fecal strains in streptomycin-treated mice. In: Levy SB, Clowes RC, Koenig EL (eds), Molecular Biology, Pathogenicity and Ecology of Bacterial Plasmids. Plenum Press, New York, p. 624.
26. Laux DC, Cabelli VJ, Cohen PS. (1982). The effect of plasmid gene expression on the colonizing ability of E. coli HS in mice. Recombinant DNA Technology Bulletin 5, 1-5.
27. Leahy JG, Colwell RR. (1990). Microbial degradation of hydrocarbons in the environment. Microbiological Reviews 54, 305-315.
28. Levy SB, Marshall B. (1981). Risk assessment studies of E. coli host-vector systems. Recombinant DNA Technology Bulletin 4, 91-98.
29. Levy SB, Marshall B, Rowse-Eagle D, Onderdonk A. (1980). Survival of Escherichia coli host-vector systems in mammalian intestine. Science 209, 391-394.
30. Lindow SE. (1985). Ecology of Pseudomonas syringae relevant to field use of Ice deletion mutants constructed in vitro for plant frost control. In: Halvorson HO, Pramer D, Rogul M (eds), Engineered Organisms in the Environment: Scientific Issues. American Society for Microbiology, Washington, DC, pp. 23-25.
31. Liu PV. (1974). Extracellular toxins of Pseudomonas aeruginosa. Journal of Infectious Disease 130, S94-S99.
32. McCullar MV, Brenner V, Adams RH, Focht DD. (1994). Construction of a novel polychlorinated biphenyl-degrading bacterium: Utilization of 3,4′-dichlorobiphenyl by Pseudomonas acidovorans M3GY. Applied and Environmental Microbiology 60, 3833-3839.
33. Michie HR, Manogue KR, Spriggs DR, Revhaug A, O'Dwyer S, Dinarello CA, Cerami A, Wolff SM, Wilmore DW. (1988). Detection of circulating tumor necrosis factor after endotoxin administration. New England Journal of Medicine 318, 1481-1486.
34. Miller JH. (1972). Experiments in Molecular Genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 433 pp.
35. Morrison DC. (1983). Bacterial endotoxins and pathogenesis. Reviews of Infectious Disease 5, S733-S747.
36. Nevola JJ, Stocker BAD, Laux DC, Cohen PS. (1985). Colonization of the mouse intestine by an avirulent Salmonella typhimurium strain and its lipopolysaccharide defective mutants. Infection and Immunity 50, 152-159.
37. Nielsen EM, Schlundt J. (1992). Use of norfloxacin to study colonization ability of Escherichia coli in in vivo and in vitro models of the porcine gut. Antimicrobial Agents and Chemotherapy 36, 401-407.
38. Obukowicz MG, Perlak FJ, Kusano-Kretzmer K, Mayer EJ, Bolten SL, Watrud LS. (1986). Tn5-mediated integration of the delta-endotoxin gene from Bacillus thuringiensis into the chromosome of root-colonizing pseudomonads. Journal of Bacteriology 168, 982-989.
39. Rylander R, Snella M. (1983). Endotoxins and the lung: cellular reactions and risk for disease. Progress in Allergy 33, 332-344.
40. Schimpff SC. (1980). Infection prevention during profound granulocytopenia. New approaches to alimentary canal microbial suppression. Annals of Internal Medicine 93, 358-361.
41. Southern PM Jr, Pierce AK, Sanford JP. (1971). Comparison of the pulmonary bactericidal capacity of mice and rats against strains of Pseudomonas aeruginosa. Applied Microbiology 21, 377-378.
42. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey TJ III, Zentella A, Albert JD, Shires GT, Cerami A. (1986). Shock and tissue injury induced by recombinant human cachectin. Science 234, 470-474.
43. Van der Waij D, Berghuis-de Vries JM, Lekkerkerk-van der Wees JEC. (1971). Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. Journal of Hygiene 69, 405-411.
44. Woods DE, Cryz SJ, Friedman RL, Iglewski BH. (1980). Pseudomonas aeruginosa in chronic lung infections of rats. Infection and Immunity 36, 1223-1228.
45. Woods DE, Sokol PA, Bryan LE, Storey DG, Mattingly SJ, Vogel HJ, Ceri H. (1991). In vivo regulation of virulence in Pseudomonas aeruginosa associated with genetic rearrangements. Journal of Infectious Disease 163, 143-149.
46. Yanze-Kontchou C, Gschwind N. (1994). Mineralization of the herbicide atrazine as a carbon source by a Pseudomonas strain. Applied and Environmental Microbiology 60, 4297-4302.